3,4-methylenedioxyamphetamine has been researched along with Cancer of Ovary in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An autocrine role of NGF in breast cancer and epithelial ovarian cancer (EOC) is evident now." | 1.35 | Neurotrophin in obstetrics and gynaecology. ( Bose, CK, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bose, CK | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Cancer of Ovary
| Article | Year |
|---|---|
Neurotrophin in obstetrics and gynaecology.
Topics: Animals; Breast Neoplasms; Embryo Implantation; Endometriosis; Female; Fetal Growth Retardation; Gyn | 2009 |